Lan Tang

USPTO Granted Patents = 64 (Patent Applications = 19)

EPO Patents = 22 (Patent Applications = 44)

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 129(Granted Patents)

Inventors with similar research interests:

Location History:

Haidian District, CN (2013)
Beijing, CN (2011 - 2022)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275967 - Processes for producing fermentation products and compositions used therein (2025-04-14),

2. 11236317 - Polypeptides having protease activity and polynucleotides encoding same (2022-02-01),

3. 10900047 - Polypeptides having beta-xylosidase activity and polynucleotides encoding same (2021-01-26),

4. 10829753 - Polypeptides having protease activity and polynucleotides encoding same (2020-11-10),

5. 10724054 - Use of serine proteases for improving ethanol yield (2020-07-28),

6. 10704034 - Polypeptides having xylanase activity and polynucleotides encoding same (2020-07-07),

7. 10577622 - Polypeptides having beta-xylosidase activity and polynucleotides encoding same (2020-03-03),

8. 10519520 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2019-12-31),

9. 10479984 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2019-11-19),

10. 10364423 - Polypeptides having beta-xylosidase activity and polynucleotides encoding same (2019-07-30),

11. 10308922 - Methods of processing textiles using polypeptides having endoglucanase activity (2019-06-04),

12. 10308921 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2019-06-04),

13. 10253342 - Polypeptides having catalase activity and polynucleotides encoding same (2019-04-09),

14. 10066251 - Polypeptides having catalase activity and polynucleotides encoding same (2018-09-04),

15. 10066237 - Polypeptides having beta-xylosidase activity and polynucleotides encoding same (2018-09-04),

Title: Innovations of Lan Tang: A Pioneering Inventor in Biotech

Introduction: Lan Tang, a prolific inventor based in Beijing, China, has made significant contributions to the field of biotechnology with an impressive portfolio of 63 patents. His work prominently focuses on developing novel polypeptides and polynucleotides, provoking advancements in protease activity and beta-xylosidase activity.

Latest Patents: Among his latest innovations, Lan Tang has patented polypeptides demonstrating protease activity along with the associated polynucleotides encoding these polypeptides. These patents disclose important nucleic acid constructs, vectors, and host cells that incorporate these polynucleotides, along with methods designed for their production and application. Another notable patent concerns isolated polypeptides exhibiting beta-xylosidase activity, again detailing the corresponding polynucleotides and providing information on their nucleic acid constructs, vectors, and host cell applications.

Career Highlights: Lan Tang's career has been marked by significant contributions to esteemed companies such as Novozymes, Inc. and Novozymes A/S. His innovative spirit and dedication to research have facilitated the development of groundbreaking biotechnological applications that hold great promise for various industries.

Collaborations: Throughout his career, Lan Tang has collaborated with notable colleagues, including Ye Liu and Junxin Duan. These collaborations have enriched his work and propelled forward the advancements in biotechnology, leading to the successful launch of several patented innovations.

Conclusion: Lan Tang stands out as a significant figure in the world of biotechnology. His extensive portfolio of patents and collaborations underscores his commitment to innovation and invention. As technology continues to evolve, Lan Tang's contributions promise to propel forward the field of biotechnology, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.